GSA Capital Partners LLP grew its stake in shares of Waters Corporation (NYSE:WAT) by 290.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,428 shares of the medical instruments supplier’s stock after buying an additional 4,038 shares during the period. GSA Capital Partners LLP’s holdings in Waters Corporation were worth $998,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Oppenheimer Asset Management Inc. increased its position in shares of Waters Corporation by 0.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after buying an additional 2 shares during the period. Watermark Asset Management Inc. bought a new position in shares of Waters Corporation in the first quarter worth approximately $106,000. First Manhattan Co. bought a new position in shares of Waters Corporation in the second quarter worth approximately $130,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of Waters Corporation in the second quarter worth approximately $160,000. Finally, Acrospire Investment Management LLC increased its position in shares of Waters Corporation by 117.4% in the second quarter. Acrospire Investment Management LLC now owns 926 shares of the medical instruments supplier’s stock worth $170,000 after purchasing an additional 500 shares during the last quarter. Hedge funds and other institutional investors own 91.00% of the company’s stock.

In other Waters Corporation news, SVP Rohit Khanna sold 18,400 shares of Waters Corporation stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the sale, the senior vice president now owns 22,477 shares of the company’s stock, valued at approximately $4,175,777.06. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Christopher A. Kuebler sold 3,500 shares of Waters Corporation stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the completion of the sale, the director now directly owns 17,849 shares in the company, valued at approximately $3,206,929.83. The disclosure for this sale can be found here. 5.07% of the stock is currently owned by company insiders.

WAT has been the topic of several research analyst reports. Bank of America Corporation restated a “neutral” rating and issued a $192.00 price objective (up from $180.00) on shares of Waters Corporation in a research report on Friday, July 21st. Wells Fargo & Company restated an “outperform” rating and issued a $205.00 price objective (up from $195.00) on shares of Waters Corporation in a research report on Thursday, July 13th. Jefferies Group LLC restated a “hold” rating and issued a $170.00 price objective on shares of Waters Corporation in a research report on Friday, July 14th. Zacks Investment Research cut shares of Waters Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Finally, Cowen and Company restated a “hold” rating and issued a $190.00 price objective on shares of Waters Corporation in a research report on Friday, July 14th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $185.50.

Shares of Waters Corporation (NYSE WAT) opened at 179.52 on Friday. The firm has a 50-day moving average price of $181.80 and a 200 day moving average price of $174.21. Waters Corporation has a 52 week low of $133.35 and a 52 week high of $190.39. The stock has a market cap of $14.33 billion, a price-to-earnings ratio of 27.06 and a beta of 0.83.

Waters Corporation (NYSE:WAT) last issued its earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.05. The company had revenue of $558.30 million for the quarter, compared to the consensus estimate of $553.22 million. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the company earned $1.58 EPS. On average, analysts forecast that Waters Corporation will post $7.39 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.watchlistnews.com/gsa-capital-partners-llp-has-998000-stake-in-waters-corporation-wat/1600609.html.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.